Cytonics Completes $4.8 Million Gross-Proceeds Financing Campaign

Clinical-stage biotechnology company adds approximately 900 new investors, expands its cap table to approximately 8,000, and brings total capital raised to $47 million JUPITER, Fla., Sept. 9, 2026 /PRNewswire/ -- Cytonics Corporation, a clinical-stage biotechnology company developing...